Skip to Main Content
UNF Limnology Students perform field work at Lake Oneida.
Salt marsh
Oyster beds
Students and professor working with a Benthic tray
gator hatchling
entire class crossing florida creek
Two Herons

Dr. Ramaswamy Narayanan

Dr. Ramaswamy Narayanan Headshot


Professor Emeritus, Charles E. Schmidt College of Science, FAU

Biomedical Program Director

Professor in Residence, UNF Department of Biology

Phone: (904) 620-3112

Office: Building 4, Room 2923


Areas of Expertise

Research Interests: Bioinformatics, Cancer gene discovery, Drug discovery, Genomics, Personalized Medicine


BS in Chemistry and Physics (1972), Bombay University, India

MS in Clinical Biochemistry (1974), Bombay University, India

Ph. D in Biochemistry (1980), National University of Ireland, Dublin

Postdoctoral Fellow (1981-1983), National Cancer Institute, Bethesda, MD


The completion of human genome sequencing efforts over a decade ago has opened new avenues for diagnosis and treatment of diverse diseases. The three Billion base pairs of the human genome hold the key to understanding Biology, disease susceptibility, response to therapy and toxicology. The information content of DNA provides a framework to deliver targeted drugs, provide a basis for DNA computing and for archival digital media storage. Bioinformatics, a highly interdisciplinary field across Science, Medicine and Computer Science has developed into a mature field with numerous datamining tools freely available in the World Wide Web. Prior to the laboratory validation of the chosen genes from the databases, increasingly, Bioinformatics and System's Biology approaches are being used to identify smart leads for treatment and diagnosis of diseases. Mining the disease and knowledge oriented databases as well as the Genome wide association studies-related databases is enabling the discovery of druggable targets and repurposed drugs for novel therapy. Over the last twenty years, my laboratory at Florida Atlantic University has used Bioinformatics approaches to discover novel druggable gene targets for the treatment of diverse diseases including autoimmune diseases, cancer, diabetes, infectious diseases including HIV, Ebola viruses and neurodegenerative diseases.